This new medication will cut the risk of developing cancer again by 30 percent and the negative effects of cancer treatments like chemotherapy by approximately 50 percent. Imagine taking a medicine that keeps a patient’s cancer from spreading or coming back for a second time. And then picture it spending just Rs 100. It appears to have occurred.
Mumbai’s Tata Memorial Centre has declared that it has found a way to stop cancer from relapsing. The institute has produced a tablet that, according to an NDTV article, will cut the likelihood of developing cancer again by 30 percent and the negative effects of cancer treatments like chemotherapy by almost 50 percent.
About the pill:
The article reported a leading cancer surgeon at Tata Memorial Hospital, Dr. Rajendra Badve, as stating that the ingredients in this tablet are copper (R+Cu) and resveratrol. Oxygen radicals produced by this mixture stop chemotherapeutic toxicity and metastases.
It is probably going to work against oral, lung, and pancreatic cancer.
How does it work?
Cancer cells undergo chromatin particle disintegration and die when a patient receives radiation therapy, chemotherapy, or surgery. These particles infiltrate healthy cells by passing through the blood. They frequently cause these healthy cells to develop into malignancies.
It is possible for these chromatin particles to merge with healthy chromosomes and result in tumours. These chromatin particles are now destroyed by oxygen particles produced by the R+Cu tablet. This tablet would produce oxygen particles in the stomach upon oral consumption, which would subsequently be absorbed into the bloodstream.
When will it be made available?
According to Dr. Badve, the pill has been submitted for clearance to the Food Safety and Standards Authority of India (FSSAI). It is anticipated to hit the market in June or July of this year. “While the budget for the treatment ranges from lakhs to crores, this tablet will be available everywhere for just Rs 100,” he explained.
In association with IDRS Labs, Bangalore, Tata Memorial Hospital, Mumbai, and the Advanced Centre for Training Research and Education in Cancer (ACTREC), Navi Mumbai, announced the introduction of the oral cancer medication “Prevall” last year. Acute lymphoblastic leukaemia and other blood-related cancers were treated with 6-mercaptopurine, a chemotherapy medication, in liquid form. The hospital has already implemented it after receiving approval from the Central Drugs Standard Control Organisation (CDSCO). Hospital pharmacies in India should soon be able to obtain it.
Comments
0 comment